Iga Swiatek tested positive for trimetazidine, a banned heart medication, leading to a one-month ban from tennis, including loss of prize money and ranking points.
Swiatek admitted to the doping violation and identified contaminated melatonin as the source, undergoing analyses to confirm its trace amounts of the banned substance in her system.
Despite her efforts to prove low fault, Swiatek faced consequences with a suspension and lost significant prize money and ranking points from her Cincinnati semifinal.
The ITIA concluded that Swiatek's actions demonstrated low fault, allowing for a reduced ban, highlighting the complexities athletes face regarding supplement contamination.
Collection
[
|
...
]